Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.320
-0.020 (-0.60%)
At close: Aug 27, 2026, 4:00 PM EDT
3.380
+0.060 (1.81%)
After-hours: Aug 27, 2026, 7:53 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $276.91 million as of August 27, 2026. Its market cap has increased by 225.92% in one year.
Market Cap
276.91M
Enterprise Value
261.75M
1-Year Change
225.92%
Ranking
Category
Stock Price
$3.32
ChartMarket Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $276.91M, a decrease of -47.13%. That is a compound annual growth rate of -12.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 276.91M | 286.73% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 286.86M |
| AC Immune | 283.37M |
| Lineage Cell Therapeutics | 283.26M |
| Sionna Therapeutics | 278.96M |
| Surrozen | 278.68M |
| Whitehawk Therapeutics | 275.92M |
| Alector | 274.68M |
| ALX Oncology Holdings | 273.79M |